| Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
| Journal website https://www.cardiologyres.org |
Original Article
Volume 3, Number 4, August 2012, pages 164-171
Depressed Exercise Peak Ejection Rate Detected on Ambulatory Radionuclide Monitoring Reflects End-Stage Cardiac Inotropic Reserve and Predicts Mortality in Ischaemic Cardiomyopathy
Figures



Tables
| Patient/age | MI site/LV structural damage | Number of coronary arteries with CAD/ extent of coronary obstructions | ADS extent as % of LV total pixels | ADS rev as % of ADS pixels | New York Heart Association classification | Follow-up results |
|---|---|---|---|---|---|---|
| *implantable cardioverter-defibrillator (ICD), ** permanent pacemaker implantation for sinus node dysfunction; coronary artery disease (CAD), myocardial infarction (MI), anterior (Ant), inferior (Inf), lateral (Lat), left anterior coronary artery (LAD), left circumflex coronary artery (LCX), right coronary artery (RCA), heart failure (HF). | ||||||
| 1/62 | Ant | 3/3 by-pass/occluded only graft to LAD | 45 | 9 | 2 | N-SURV (Fatal MI) |
| 2/62 | Ant/prior LV aneurysm resection | 2/occluded LAD/ LCX with 90% stenosis | 60 | 2 | 3 | N-SURV (HF) |
| 3/69 | Ant, Inf, Lat | 3/patent stent to RCA and LCX, LAD with 50% stenosis | 49 | 0 | 3 | SURV |
| 4/76 | Ant, Inf | 1/occluded stent to LAD | 29 | 55 | 3 | SURV |
| 5/74 | Ant, Inf, Lat /LV aneurysm | 1/occluded LAD | 11 | 0 | 2 | N-SURV (HF) |
| 6/74 | Ant | 3/3 by-pass with only occluded graft to LAD | 25 | 10 | 3 | N-SURV (HF) |
| **7/78 | Ant | 1/LAD with 30% stenosis | 15 | 82 | 2 | SURV |
| 8/72 | Inf/valvular aortic stenosis | coronary arteries with minimal obstructions | 8 | 0 | 2 | SURV |
| 9/53 | Ant, Inf, Lat | coronary arteries with minimal obstructions /vasospastic angina | 22 | 0 | 2 | SURV |
| 10/50 | Inf | ectatic LAD | 7 | 0 | 2 | SURV |
| 11/62 | Ant, Inf | coronary arteries with minimal obstructions | 20 | 5 | 2 | SURV |
| **12/67 | Ant | 3/3 by-pass with only 2 occluded grafts | 28 | 5 | 3 | N-SURV (HF) |
| *13/68 | Ant, Lat | 3/severe stenosis not eligible for revascularisation | 47 | 17 | 3 | N-SURV (HF) |
| *14/68 | Ant, Lat, Inf | 1/patent stent to RCA | 27 | 0 | 2 | N-SURV |
| 15/64 | Ant | 1/occluded LAD | 21 | 0 | 2 | SURV |
| N-SURV | SURV | N-SURV vs. SURV | ||||||
|---|---|---|---|---|---|---|---|---|
| rest | P | exercise | rest | P | exercise | rest P | exercise P | |
| HR/bpm | 88 ± 11 | 0.2 | 97 ± 17 | 83 ± 12 | 0.001 | 106 ± 10 | 0.4 | 0.2 |
| EDV(mL) | 105 ± 5 | 0.2 | 97 ± 16 | 102 ± 5 | 0.7 | 105 ± 22 | 0.2 | 0.4 |
| ESV(mL) | 80 ± 8 | 0.02 | 65 ± 20 | 65 ± 11 | 0.02 | 52 ± 16 | 0.008 | 0.2 |
| % EF | 25 ± 7 | 0.01 | 34 ± 10 | 38 ± 9 | 0.01 | 50 ± 13 | 0.01 | 0.02 |
| PFR(edv/s) | 1.3 ± 0.3 | 0.01 | 1.9 ± 0.6 | 1.3 ± 0.4 | 0.01 | 2.7 ± 0.9 | 0.9 | 0.06 |
| PER(edv/s) | 1.4 ± 3 | 0.01 | 2 ± 0.6 | 2.3 ± 0.6 | 0.01 | 3.3 ± 0.7 | 0.003 | 0.003 |